Elsevier

Journal of Alloys and Compounds

Volume 737, 15 March 2018, Pages 347-355
Journal of Alloys and Compounds

PEG mediated shape-selective synthesis of cubic Fe3O4 nanoparticles for cancer therapeutics

https://doi.org/10.1016/j.jallcom.2017.12.028Get rights and content

Highlights

  • A facile strategy is developed for synthesis of PEGylated cubic Fe3O4 nanoparticles.

  • PEGylated nanoparticles are water-dispersible, non-toxic and protein resistant.

  • Good binding affinity for positively charged anticancer drug, doxorubicin (DOX).

  • Possess good cellular uptake and therapeutic efficacy upon conjugated with DOX.

  • Nanoparticles can also be used as effective thermoseed for hyperthermia therapy.

Abstract

A facile strategy for shape-selective synthesis of PEGylated Fe3O4 cubic magnetic nanoparticles (PCMN) by thermal decomposition of Fe (III) acetylacetonate was developed and explored their applications in drug delivery and hyperthermia. The structural analysis by XRD and TEM showed the formation of spinel-structured Fe3O4 nanoparticles of good crystallinity. The presence of carboxyl PEG group on the surface of PCMN provides colloidal stability, non-toxicity and protein resistance characteristics to them. These negatively charged PCMN have high electrostatic binding affinity for positively charged anticancer drug, doxorubicin hydrochloride (DOX) and followed pH responsive release behaviour. The in-vitro cytotoxicity studies using normal human fibroblast (NIH 3T3) cells did not show any significant toxicity when cells were treated with PCMN. However, DOX loaded PCMN (PCMN-DOX) exhibit good cellular internalization and substantial toxicity to mouse skin fibrosarcoma (WEHI-164) cells. In addition, the superparamagnetic nature of these particles with optimal magnetization and excellent specific absorption rate (SAR) under external AC magnetic field makes it a valuable system which can be further used as an effective heating agent for hyperthermia treatment of cancer.

Introduction

The development of nanomaterials with controlled size and shape continues to cumulate widespread attention because of their exclusive physico-chemical properties, which make them distinct from their atomic as well as bulk counterparts [1], [2]. Although a large variety of nanomaterials are being used in biomedical applications, the magnetic nanoparticles (MNPs) seem to hold the utmost potential of achievement. They are already established in clinical use as contrast agent for magnetic resonance imaging (MRI) [3]. In addition to this, MNPs have found potential applications in magnetic drug targeting and non-invasive hyperthermia therapy [4]. Among the abundant array of MNPs, superparamagnetic iron oxide (Fe3O4) nanoparticles have turned up as delicate therapeutic vehicle for these applications [5], [6], [7], [8], [9], [10]. The applicability of Fe3O4 nanoparticles depends upon their size, size distribution, surface functionality, aqueous colloidal stability and biocompatibility [11], [12], [13], [14]. These characteristics are highly dependent on the method of preparation, type of precursors and coating agents. Numerous methods such as co-precipitation, thermal decomposition, microemulsion and hydrothermal synthesis etc. are extensively employed for preparation of Fe3O4 nanoparticles of well-defined sizes, shapes and other physical properties [15], [16], [17], [18], [19]. Among these, thermal decomposition of organometallic precursors of iron in presence of surfactants in high boiling solvent is highly favoured for the preparation of Fe3O4 MNPs with high crystallinity and uniform particle size distribution [16], [20]. Further, this method is also used for preparation of different shaped Fe3O4 particles by adjusting reaction parameters such as surfactant/precursor ratio, heating rate, reaction time and use of co-surfactants etc [20], [21], [22], [23]. The particle anisotropy (associated with both shape and surface morphology) strongly influences the transverse relaxivity as well as heating efficacy of MNPs [24]. However, thermal decomposition method mainly yields organic-soluble hydrophobic MNPs, which needs to be functionalized with suitable bioactive ligands for their water-solubility and biocompatibility [18], [21]. Therefore, the surface modification of Fe3O4 MNPs with desired functionality is crucial for biomedical applications. Further, the functional moieties provide sites for binding of therapeutic molecules such as anticancer drugs or antibodies.

Amongst the others, poly(ethylene glycol) (PEG) has been found to be a favourable coating agent due to its biocompatible and hydrophilic nature [16], [25], [26]. In addition, non-immunogenic properties and resistance to plasma protein deposition make it as a unique surface modifying agent. This PEGylation makes them improved nanocarriers for therapeutic applications by providing protein resistance characteristics and increased blood circulation time [27], [28]. For instance, Ruiz et al. [29] reported that the residence time in blood was doubled for Fe3O4 MNPs modified with PEG as compared to their bare counterpart and consequently particle accumulation in liver and spleen was reduced. However, they employed multistep coating procedure for developing water-dispersible magnetite nanoparticles (obtained via thermal decomposition of an iron coordination complex). Thus, the development of cost effective methods for the preparation of PEG coated uniform sized Fe3O4 MNPs would be of extreme importance. Herein, we report a facile strategy for one-pot synthesis of water-dispersible, PEGylated Fe3O4 cubic magnetic nanoparticles (PCMN) by thermal decomposition of iron (III) acetylacetonate in presence of carboxyl terminated PEG-diacid using PEG as a solvent. The presence of the free carboxyl group on the surface of PCMN provides aqueous colloidal stability, non-toxicity and protein resistance properties to them. These PCMN have high affinity for electrostatic binding of positively charged anticancer drug, DOX. It has been observed that DOX in conjugation with PCMN retained good therapeutic efficacy and showed substantial cellular internalization in WEHI-164 cells. In addition, these nanoparticles possess superparamagnetic behaviour and excellent heating efficacy under external AC magnetic field.

Section snippets

Materials

Iron (III) acetylacetonate (97%), poly(ethylene glycol) (PEG, Mn = 600), PEG diacid (poly(ethylene glycol) bis(carboxymethyl) ether, Mn = 600), doxorubicin hydrochloride (DOX, 98%), and bovine serum albumin (BSA) were purchased from Sigma Aldrich, USA. Sodium acetate, ferrous ammonium sulphate and 1, 10-phenanthroline monohydrate were procured from SRL Pvt. Ltd., India. NIH 3T3 and WEHI-164 cells were obtained from National Centre for Cell Science (NCCS), India. Dulbecco's Modified Eagle Medium

Results and discussion

PEG and PEG-diacid mixture play multiple roles in the formation of highly crystalline Fe3O4 nanoparticles. They not only serve as solvent and complexing agents for the iron but also stabilize the resulting nanoparticles. Our synthesis protocol does not involve multiple steps and use of surfactants such as oleic acid, oleylamine, 1,2-dodecanediol and 1,2-hexadecanediol etc. which are commonly used in thermal decomposition method [17], [31], [32], [33]. Moreover, the PEGylation of nanoparticles

Conclusions

We have demonstrated a simple and one-pot synthesis method for preparation of water-dispersible, negatively charged PEGylated cubic shaped Fe3O4 nanoparticles. The free carboxyl groups present on the surface of PCMN provide colloidal stability, biocompatibility and protein resistance characteristics to the particles. Thus, these particles can be readily usable for various biomedical applications without subsequent surface modifications. The negatively charged PCMN showed good binding affinity

References (53)

  • S.L. Gawali et al.

    Effect of sugar alcohol on colloidal stabilization of magnetic nanoparticles for hyperthermia and drug delivery applications

    J. Alloy. Compd.

    (2017)
  • K.C. Barick et al.

    Glycine passivated Fe3O4 nanoparticles for thermal therapy

    J. Colloid Interface Sci.

    (2012)
  • R. Hergt et al.

    Magnetic particle hyperthermia-biophysical limitations of a visionary tumour therapy

    J. Magn. Magn. Mater.

    (2007)
  • D.L. Huber

    Synthesis, properties and applications of iron nanoparticles

    Small

    (2005)
  • R.G. Chaudhuri et al.

    Core/shell nanoparticles: classes, properties, synthesis mechanisms, characterization and applications

    Chem. Rev.

    (2012)
  • Y.X.J. Wáng et al.

    A comprehensive literature update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging

    Quant. Imag. Med. Surg.

    (2017)
  • O.L. Gobbo et al.

    Magnetic nanoparticles in cancer theranostics

    Theranostics

    (2015)
  • D. Dorniani et al.

    Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery

    Int. J. Nanomed.

    (2012)
  • K.C. Barick et al.

    pH-responsive peptide mimic shell cross-linked magnetic nanocarriers for combination therapy

    Adv. Funct. Mater.

    (2012)
  • E.V.E. Zapata et al.

    Adherence of paclitaxel drug in magnetite chitosan nanoparticles

    J. Alloy. Compd.

    (2012)
  • J. Majeed et al.

    Water-dispersible polyphosphate-grafted Fe3O4 nanomagnets for cancer therapy

    RSC Adv.

    (2015)
  • J.-P. Fortin et al.

    Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia

    J. Am. Chem. Soc.

    (2007)
  • F. Hu et al.

    Highly dispersible, superparamagnetic magnetite nanoflowers for magnetic resonance imaging

    Chem. Commun.

    (2010)
  • J. Sangeetha et al.

    Functionalization of iron oxide nanoparticles with biosurfactants and biocompatibility studies

    J. Biomed. Nanotechnol.

    (2013)
  • S. Rana et al.

    Stimuli responsive carboxyl PEGylated Fe3O4 nanoparticles for therapeutic applications

    J. Nanofluids

    (2015)
  • K.C. Barick et al.

    Novel and efficient MR active aqueous colloidal Fe3O4 nanoassemblies

    J. Mater. Chem.

    (2009)
  • Cited by (0)

    View full text